Inventor · disambiguated record
Steen Knudsen
Also filed as: KNUDSEN STEEN · KNUDSEN STEEN HOJRUP
9 granted patents·12 pending applications·75 citations·filing 2001–2024
84Inventor score
Files withOncology Venture ApS9KNUDSEN STEEN3MEDICAL PROGNOSIS INST A S3TIMMONS JAMES2ALLARITY THERAPEUTICS INC1
Top patents by PatentIndex Score
21 records- 0193US9725769B1Methods for predicting drug responsiveness in cancer patientsOncology Venture ApS·Filed 2016·Granted Aug 8, 2017·32 cites·29 claims
- 0291US8445198B2Methods, kits and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacyKNUDSEN STEEN·Filed 2008·Granted May 21, 2013·34 cites·84 claims
- 0385US9598734B2Methods and devices for predicting treatment efficacyKNUDSEN STEEN·Filed 2011·Granted Mar 21, 2017·7 cites·28 claims
- 0476US10907214B2Methods for predicting drug responsiveness in cancer patientsOncology Venture ApS·Filed 2017·Granted Feb 2, 2021·1 cites·26 claims
- 0570US10392667B2Methods and devices for predicting treatment efficacy of fulvestrant in cancer patientsMEDICAL PROGNOSIS INST A/S·Filed 2014·Granted Aug 27, 2019·1 cites·25 claims
- 0667US2011195412A1Predictive Biomarkers for Response to ExerciseTIMMONS JAMES·Filed 2009·Application pending·0 cites
- 0766US11421284B2Methods for predicting drug responsiveness in cancer patientsOncology Venture ApS·Filed 2020·Granted Aug 23, 2022·0 cites·20 claims
- 0865US2024325396A1Methods for treating cancerALLARITY THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0961US10835531B1Methods for predicting drug responsiveness in cancer patientsOncology Venture ApS·Filed 2019·Granted Nov 17, 2020·0 cites·24 claims
- 1060US2014094381A1Predictive Biomarkers for Response to ExerciseTIMMONS JAMES·Filed 2013·Application pending·0 cites
- 1159US2018100197A1Methods for predicting drug responsiveness in cancer patientsOncology Venture ApS·Filed 2017·Application pending·0 cites
- 1254US2022362240A1Methods for predicting drug responsiveness in cancer patientsOncology Venture ApS·Filed 2020·Application pending·0 cites
- 1351US10900089B2Methods for predicting drug responsiveness in cancer patientsOncology Venture ApS·Filed 2018·Granted Jan 26, 2021·0 cites·30 claims
- 1451US2023062248A1Methods for predicting ixabepilone responsiveness in cancer patientsAllarity Therapeutics Europe ApS·Filed 2021·Application pending·0 cites
- 1549US2021222252A1Methods for predicting drug responsiveness in cancer patientsOncology Venture ApS·Filed 2019·Application pending·0 cites
- 1645US2014106986A1Methods and devices for prognosis of cancer relapseKNUDSEN STEEN·Filed 2012·Application pending·0 cites
- 1741US2018087113A1Methods for predicting drug responsiveness in cancer patientsOncology Venture ApS·Filed 2016·Application pending·0 cites
- 1840US2019231795A1Methods for treating cancer and predicting drug responsiveness in cancer patientsLIPLASOME PHARMA APS·Filed 2019·Application pending·0 cites
- 1936US10570457B2Methods for predicting drug responsivenessMEDICAL PROGNOSIS INST A/S·Filed 2015·Granted Feb 25, 2020·0 cites·15 claims
- 2035US2016199399A1Methods for predicting drug responsiveness in cancer patientsMEDICAL PROGNOSIS INST A S·Filed 2016·Application pending·0 cites
- 2128US2003131898A1Method of assembling two carcass endsFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Steen Knudsen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →